Not Enough Dichotomies
View Presentation View Presentation
*Thomas Permutt, FDA 

Keywords: benefit, risk, missing

Reducing continuous outcomes to single dichotomies is bad. The badness comes not from dichotomizing, but rather from dichotomizing only once. Multiple cuts preserve all the information but enable additional interpretations. Potential advantages include rational handling of dropouts and better informed clinical decision-making.